Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 18 June 2002
Vol. 2002, Issue 137, p. tw215
[DOI: 10.1126/stke.2002.137.tw215]

EDITORS' CHOICE

Neurodegeneration Huntingtin Phosphorylation

Huntington's disease (HD) is characterized by progressive brain neurodegeneration, often leading to dementia. A mutation in the huntingtin protein and nuclear accumulation of the mutant are associated with the pathology of HD, but it is not yet clear how the mutant protein induces the death of neurons. Growth factors that promote cell survival are attractive therapeutic agents for HD; Humbert et al. report that insulin-like growth factor 1 (IGF-1) shows just such neuroprotective potential. IGF-1 promotes cell survival through activation of the serine-threonine kinase Akt. The study shows that a specific serine residue in huntingtin is phosphorylated by Akt both in vitro and in neuronal cells in response to IGF-1. Furthermore, this IGF-1-induced modification blocked the formation of nuclear inclusions and neuronal apoptosis. Brain samples from HD patients also showed decreased amounts of Akt. Phosphorylation by Akt may alter HD interactions with proteins that promote apoptosis and, hence, abrogate its toxicity.

S. Humbert, E. A. Bryson, F. P. Cordelieres, N. C. Connors, S. R. Datta, S. Finkbeiner, M. E. Greenberg, F. Saudou, The IGF-1 pathway is neuroprotective in Huntingon's disease and involves huntingtin phosphorylation by Akt. Dev. Cell 2, 831-837 (2002). [Online Journal]

Citation: Huntingtin Phosphorylation. Sci. STKE 2002, tw215 (2002).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882